Unveiling the psychosocial impact of Elexacaftor/Tezacaftor/Ivacaftor therapy in Cystic Fibrosis patients

BMC Pulmonary Medicine

Table 4 Correlation between anxiety and depression throughout study

Groups	ICC^a	LCI^b	UCI^c	Interval length	p-value	Classification
Classification of Anxiety and Depression
Total	0.560	0.499	0.615	0.116	< 0.001	Moderate
0 Months	0.370	0.196	0.522	0.326	< 0.001	Discrete
3 Months	0.644	0.518	0.742	0.224	< 0.001	Substantial
6 Months	0.761	0.668	0.830	0.162	< 0.001	Substantial
9 Months	0.549	0.403	0.669	0.266	< 0.001	Moderate
12 Months	0.517	0.368	0.643	0.275	< 0.001	Moderate

ISSN: 1471-2466